These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2112473)

  • 1. Selective chemoprophylaxis guided by multifactorial analysis in superficial bladder cancer.
    Vera-Donoso CD; Llopis B; Oliver F; Gallego J; Ruiz J; Vidal J; Jiménez Cruz JF
    Eur Urol; 1990; 17(3):219-22. PubMed ID: 2112473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Directed chemotherapy in superficial carcinoma of the bladder conditioned by the knowledge of recurrence factors].
    Oliver F; Llopis B; Vera C; Domínguez C; Vidal J; Gallego J; Jiménez JF
    Actas Urol Esp; 1989; 13(1):41-3. PubMed ID: 2496584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crossed chemoprophylaxis assay between adriamycin and cis-platinum in recurrent superficial bladder tumor.
    Llopis B; Gallego J; Mompó JA; Boronat F; Alonso M; Moreno B; Jiménez JF
    Eur Urol; 1986; 12(4):253-6. PubMed ID: 3091370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of thiotepa, adriamycin and cisplatin in the prophylaxis of recurrence of superficial bladder carcinoma in a group of 217 patients].
    Llopis B; Gallego J; Boronat F; Moreno B; Mompó JA; Jiménez JF
    Actas Urol Esp; 1986; 10(4):225-30. PubMed ID: 3092589
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prognostic factors and risk of recurrence in a series of 385 patients with superficial bladder carcinoma treated with thiotepa, adriamycin or cisplatin].
    Llopis B; Sánchez A; Boronat F; Gallego J; Moreno B; Alonso M; Martínez R; Vera CD; Jiménez JF
    Arch Esp Urol; 1987 Apr; 40(3):159-64. PubMed ID: 3113347
    [No Abstract]   [Full Text] [Related]  

  • 6. Cooperative studies of chemoprophylaxis after transurethral resection of bladder tumors.
    Pavone-Macaluso M; Tripi M; Ingargiola GB
    Cancer Chemother Pharmacol; 1983; 11 Suppl():S16-21. PubMed ID: 6416698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravesical chemotherapy.
    Prout GR
    Prog Clin Biol Res; 1984; 162B():125-50. PubMed ID: 6438639
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M; McGarry R; Kupelnick B
    Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary superficial bladder carcinoma. Prognostic factors for recurrence].
    Jiménez Cruz JF; Llopis Minguez B; Vera Donoso CD
    Arch Esp Urol; 1990; 43 Suppl 2():139-47. PubMed ID: 2096775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravesical thiotepa and mitomycin C treatment immediately after transurethral resection and later for superficial (stages Ta and Tis) bladder cancer: a prospective, randomized, stratified study with crossover design.
    Zincke H; Benson RC; Hilton JF; Taylor WF
    J Urol; 1985 Dec; 134(6):1110-4. PubMed ID: 3932685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history and treatment of low and high risk superficial bladder tumors.
    Rübben H; Lutzeyer W; Fischer N; Deutz F; Lagrange W; Giani G
    J Urol; 1988 Feb; 139(2):283-5. PubMed ID: 3339726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resume of selected studies of the National Bladder Cancer Collaborative Group A and new protocols.
    Prout GR; Kopp J
    Prog Clin Biol Res; 1984; 162B():397-427. PubMed ID: 6438644
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant intravesicular pharmacotherapy for superficial bladder cancer.
    Lum BL; Torti FM
    J Natl Cancer Inst; 1991 May; 83(10):682-94. PubMed ID: 1827165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Low-grade, low-stage transitional carcinoma of the bladder. Analysis of 147 cases].
    Escudero Barrilero A; Gutiérrez Sanz-Gadea C; Hernández Fernández C; Mateos Torres A; Maganto Pavón E; Mayayo Dehesa T
    Actas Urol Esp; 1985; 9(2):135-46. PubMed ID: 3925729
    [No Abstract]   [Full Text] [Related]  

  • 15. Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer.
    Martínez-Piñeiro JA; Jiménez León J; Martínez-Piñeiro L; Fiter L; Mosteiro JA; Navarro J; García Matres MJ; Cárcamo P
    J Urol; 1990 Mar; 143(3):502-6. PubMed ID: 2106041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials in superficial and invasive bladder cancer.
    Smith PH
    Turk J Pediatr; 1984; 26(1-4):251-63. PubMed ID: 6443168
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of intravesical thiotepa in the management of superficial bladder cancer. National Bladder Cancer Collaborative Group A.
    Cancer Res; 1977 Aug; 37(8 Pt 2):2916-7. PubMed ID: 406040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term versus short-term doxorubicin hydrochloride instillation after transurethral resection of superficial bladder cancer.
    Flamm J
    Eur Urol; 1990; 17(2):119-24. PubMed ID: 2178939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Directed chemotherapy in superficial carcinoma conditioned by the knowledge of relapse factors].
    Oliver F; Llopis B; Vera C; Domínguez C; Vidal J; Gallego J; Jiménez JF
    Actas Urol Esp; 1988; 12(5):419-23. PubMed ID: 3218579
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative study of 62 patients randomly treated with adriamycin or cisplatin as chemoprophylaxis of their superficial bladder carcinoma].
    Iborra Juan I; Monrós Lliso JL; Ricós Torrent JV; Mazcuñan Fuentes F; Casanova Ramón-Borja J; Solsona Narbón E
    Actas Urol Esp; 1988; 12(1):20-4. PubMed ID: 3389211
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.